載入...
Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy
Background and objective The rate of end-stage renal disease from lupus nephritis has not declined, in spite of recent advances in therapeutics, such as mycophenolate mofetil (MMF). To provide insight into rates of the clinical outcomes in current practice after biopsy-proven lupus nephritis, we use...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5796813/ https://ncbi.nlm.nih.gov/pubmed/29410944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1907 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|